 Pancreatic Neoplasms
"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Descriptor ID |
D010190
|
| MeSH Number(s) |
C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
|
| Concept/Terms |
Pancreatic Neoplasms- Pancreatic Neoplasms
- Neoplasm, Pancreatic
- Pancreatic Neoplasm
- Pancreas Neoplasms
- Neoplasm, Pancreas
- Neoplasms, Pancreas
- Pancreas Neoplasm
- Neoplasms, Pancreatic
Cancer of Pancreas- Cancer of Pancreas
- Pancreas Cancers
- Pancreas Cancer
- Cancer, Pancreas
- Cancers, Pancreas
- Pancreatic Cancer
- Cancer, Pancreatic
- Cancers, Pancreatic
- Pancreatic Cancers
- Cancer of the Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".
This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 | | 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 1 | 1 | 2 | | 2000 | 4 | 0 | 4 | | 2001 | 2 | 0 | 2 | | 2002 | 5 | 2 | 7 | | 2003 | 6 | 2 | 8 | | 2004 | 5 | 3 | 8 | | 2005 | 4 | 1 | 5 | | 2006 | 15 | 1 | 16 | | 2007 | 9 | 4 | 13 | | 2008 | 16 | 2 | 18 | | 2009 | 27 | 3 | 30 | | 2010 | 28 | 3 | 31 | | 2011 | 29 | 0 | 29 | | 2012 | 31 | 5 | 36 | | 2013 | 23 | 2 | 25 | | 2014 | 21 | 3 | 24 | | 2015 | 22 | 1 | 23 | | 2016 | 28 | 3 | 31 | | 2017 | 26 | 3 | 29 | | 2018 | 25 | 2 | 27 | | 2019 | 40 | 2 | 42 | | 2020 | 30 | 2 | 32 | | 2021 | 30 | 0 | 30 | | 2022 | 26 | 1 | 27 | | 2023 | 30 | 0 | 30 | | 2024 | 43 | 6 | 49 | | 2025 | 21 | 1 | 22 |
To return to the timeline, click here.
Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.
-
Cohen DJ, Goldberg JD, Leichman L, Hochman T, Newman E, Du K, Megibow A, Oberstein P, Al-Rajabi R, Scott AJ, Bekaii-Saab T, Messersmith WA, Weekes C. Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study. Oncologist. 2025 Oct 01; 30(10).
-
Suljagic A, Swartling O, Henningson ES, Ansorge C, Gilg S, Sparrelid E, Ghorbani P. Postoperative Cholangitis After Pancreatoduodenectomy: A Frequent Late Complication Demanding Standardized Prevention and Treatment Protocols. Ann Surg Oncol. 2025 Dec; 32(13):10007-10016.
-
Wainberg ZA, Weekes CD, Furqan M, Kasi PM, Devoe CE, Leal AD, Chung V, Perry JR, Kheoh T, McNeil LK, Welkowsky E, DeMuth PC, Haqq CM, Pant S, O'Reilly EM. Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results. Nat Med. 2025 Nov; 31(11):3648-3653.
-
Barrett A, Maslanka MD, Darula Z, McCabe MC, Saviola AJ, Schmitt LR, Weaver V, Pitts TM, Messersmith WA, Hansen KC. Pancreatic Cancer Progression Involves Increased Lysyl Oxidase-Mediated Collagen Cross-Links as Part of the Desmoplastic Reaction. Biochemistry. 2025 Aug 19; 64(16):3515-3525.
-
Sun Y, Fujiwara Y, Torphy RJ, Yee EJ, Guo Y, Sun Z, Hu J, Eck E, Terai T, Schulick RD, Zhu Y. CD93 blockade overcomes sunitinib resistance in pancreatic neuroendocrine tumors. Mol Ther. 2025 Oct 01; 33(10):5017-5027.
-
Hasselgren K, Williamsson C, Wennerblom J, Ghorbani P, Liljefors MG, Huhta H, Heby M, Månsson C, Johansson MI, Elander NO, Nortunen M, Kallio R, Halimi A, Öhlund D, Sandström P, Sparrelid E, Björnsson B. Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol. BMC Surg. 2025 Jul 19; 25(1):299.
-
Bonsdorff A, Kjeseth T, Sahakyan M, Kirkegård J, de Ponthaud C, Ghorbani P, Wennerblom J, Williamson C, Acher AW, Thillai M, Tarvainen T, Uutela A, Sirén J, Kokkola A, Hagen RE, Lund A, Nielsen MF, Fristedt R, Biörserud C, Bratlie SO, Tingstedt B, Labori KJ, Gaujoux S, Wigmore SJ, Hallet J, Sparrelid E, Kleive D, Sallinen V. Impact of neoadjuvant therapy on short-term outcomes after left pancreatectomy: A propensity score-matched international multicenter study. Surgery. 2025 Sep; 185:109552.
-
Perri G, Engstrand J, Wright RD, Bronzwaer SFC, Kroese TE, Huang B, Acidi B, Vitale A, Tran Cao HS, van Hillegersberg R, Nilsson M, Sparrelid E, Katz MHG, Marchegiani G, Cillo U. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open. 2025 Jul 01; 9(4).
-
Gao S, Jangili K, Akinlalu A, Ogberefor E, Gao T, Devaraj K, Sun D. Microscopic nucleic acid-to-protein ratio: A label-free approach for pancreatic cancer detection. Biosens Bioelectron. 2025 Nov 01; 287:117727.
-
Khomiak A, Balmaceda NB, Ghaffar SA, Lieu CH, Del Chiaro M, Messersmith WA, Lentz RW. Oligometastatic pancreatic cancer: current state of management and emerging therapies. Oncologist. 2025 Jun 04; 30(6).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|